GHK-Cu 50 mg is a naturally occurring copper-binding research compound (glycyl-L-histidyl-L-lysine:copper), first identified in human plasma in 1973, supplied for laboratory research only.
Key Research Areas
- Gene expression: Studied for its influence on large sets of genes involved in tissue remodelling, antioxidant defence and cell signalling.
- Extracellular matrix: Examined for effects on collagen and elastin synthesis in cell culture models.
- Wound-repair models: Studied in preclinical models of tissue remodelling and inflammation.
- Format: Lyophilised (freeze-dried) powder, 50 mg per vial.
Research Background
GHK-Cu levels are reported to decline with age, which has made it a subject of interest in ageing and dermal biology research. Its multifunctional activity is studied in laboratory models, and findings should not be extrapolated to humans.
Storage
Store the lyophilised powder in a cool, dark place, or refrigerate at 2°C to 8°C. Once reconstituted with bacteriostatic water, keep chilled and use within the recommended laboratory timeframe.
For laboratory and research purposes only. Not for human consumption, medical use, or veterinary use.
